Delivery Order SPE2DB22D1017-SPE2DB25FG1LM
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,143,796 units of Droxidopa 300 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and a ceiling value of $30,036.24, with a performance period extending until May 6, 2025. The contract is not set aside for any specific...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of 4,566,148,800 units of the medication droxidopa 300 mg capsules. The contract has a firm fixed price of $5,122.05 and a period of performance through October 21, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $4,030.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,115,953 units of the prescription medication droxidopa 100 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 5, 2025. It is not designated as a set-aside contract, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.40 firm fixed price delivery order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a period of performance through February 26, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a ceiling value of $37,579.10 and a performance period through March 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6MVR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200 mg Droxidopa capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $22,532.79 and a performance period through April 30, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $60,045.24 and is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award, identified as SPE2DB25D3018|SPE2DB25FUXMP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,236,364 units of DROXIDOPA 300 MG CAPSULE 90S, a medication, with a ceiling value of $28,310.61. The contract is a firm fixed-price arrangement with a period of performance extending to May 14, 2025. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $6,776.80, is a delivery order placed by the Defense Logistics Agency (DLA) to supply 4,564,666,798 units of the prescription medication droxidopa 200 mg capsule in quantities of 90s. The award has no set-aside designation and is a firm fixed-price contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products, including medications across various therapeutic areas such as diabetes, neurology, and pain management. The contract has a ceiling value of $5,386.07 and a period of performance through May 14, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor,...